Skip to content

Jennifer M Mundt

Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

2 papers in the library · 10 citations · publishing 2024-2025

Papers

Treating narcolepsy-related nightmares with cognitive behavioural therapy and targeted lucidity reactivation: A pilot study.

Journal of sleep research June 1, 2025 Jennifer M Mundt, Kristi E Pruiksma, Karen R Konkoly et al. 7 citations

A small trial tested cognitive behavioral therapy for nightmares (CBT-N), adapted for people with narcolepsy, with or without targeted lucidity reactivation (TLR) to enhance lucid dreaming. Six adults who had frequent nightmares (at least 3 per week) received seven treatment sessions. Nightmare frequency dropped from an average of 8.38 per week to 2.25 per week, a large improvement. Nightmare severity and symptoms such as sleep paralysis, hallucinations, and dream enactment also improved. The three participants who received TLR all recalled dreams related to their rescripted nightmare. Participants reported reduced shame and anxiety about sleep and nightmares. The findings offer preliminary evidence that CBT-N and TLR may help manage narcolepsy-related nightmares.

Development of a mindfulness-based intervention for narcolepsy: a feasibility study.

Sleep October 11, 2024 Jennifer M Mundt, Phyllis C Zee, Matthew D Schuiling et al. 3 citations

A remote mindfulness-based intervention adapted for narcolepsy was tested in three program lengths: brief (4 weeks), standard (8 weeks), and extended (12 weeks) among 60 adults with narcolepsy. Attendance, meditation practice, and data completeness benchmarks were met by 71.7%, 61.7%, and 78.3% of participants, respectively. All groups showed clinically meaningful improvements in mindfulness, self-compassion, self-efficacy for managing emotions, positive psychosocial impact, global mental health, and fatigue. Standard and extended groups also improved anxiety and depression; the extended group additionally improved social and cognitive functioning, daytime sleepiness, hypersomnia symptoms, and hypersomnia-related functioning. The extended program appears to offer the most clinical benefit while maintaining engagement.